HomeOwner SearchCategory Search
Visit USCOBispecific Antibodies for the Treatment of Co-circulating Flaviviruses and Antibody Derivatives for Diagnostics in Checkpoint Immunotherapy
Text Registration
Copyright Title
Bispecific Antibodies for the Treatment of Co-circulating Flaviviruses and Antibody Derivatives for Diagnostics in Checkpoint Immunotherapy
Status
Published
on 1 Jan 2020
Year of Creation
2019
Copyright Claimant
Adrian Esqueda
Registration Number
TX0008833788
on 1 Jan 2020Copyright Summary
The U.S. Copyright record (Registration Number: TX0008833788) dated 1 Jan 2020, pertains to an electronic file (eService) titled "Bispecific Antibodies for the Treatment of Co-circulating Flaviviruses and Antibody Derivatives for Diagnostics in Checkpoint Immunotherapy" created in 2019. The copyright holder is Adrian Esqueda, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Adrian Esqueda.
Application Details
Registration Number
TX0008833788
Registration Date
1/1/2020
Year of Creation
2019
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com
Statements
Application Title Statement: Bispecific Antibodies for the Treatment of Co-circulating Flaviviruses and Antibody Derivatives for Diagnostics in Checkpoint Immunotherapy
Author Statement: Adrian Esqueda Citizenship: not known Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.